BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1266422)

  • 1. [Ceruloplasmin and immunoglobulins under controlled D-penicillamine therapy in rheumatoid arthritis].
    Schmidt KL; Ott VR
    Z Rheumatol; 1976; 35(3-4):154-63. PubMed ID: 1266422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of D-penicillamine on serum immunoglobulins in rheumatoid arthritis].
    Gambari PF; Mioni E; Ostuni A; Volante D; Punzi L; Todesco S; Ongaro G
    Boll Soc Ital Biol Sper; 1981 May; 57(10):1127-31. PubMed ID: 6794580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating protein complexes in D-penicillamine therapy of rheumatoid arthritis. Correlation between IgG- and alpha 1-antitrypsin-IgA complexes and clinical response.
    Norberg R; Wollheim FA; Gedda PO
    Acta Med Scand; 1980; 208(5):393-6. PubMed ID: 6969974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two-phase course of IgM and rheumatoid factors during D-penicillamine therapy].
    Stojan B; Hasler F
    Z Rheumatol; 1977; 36(5-6):194-9. PubMed ID: 302538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis.
    Epstein O; De Villiers D; Jain S; Potter BJ; Thomas HC; Sherlock S
    N Engl J Med; 1979 Feb; 300(6):274-8. PubMed ID: 759879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A benign form of rheumatoid arthritis, associated with low IgG, IgM and IgA and C3-proactivator concentrations in the serum].
    Stojan B; Hasler F
    Z Rheumatol; 1980; 39(5-6):182-9. PubMed ID: 6903082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
    Warnatz H; Scheiffarth F; Gutmann W
    Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunglobulin G-, M- and A-levels after 3 and 6 days intravenous treatment by D-penicillamin (author's transl)].
    Cegla UH
    Z Immunitatsforsch Exp Klin Immunol; 1975 Sep; 150(2):184-7. PubMed ID: 127474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum copper and zinc in rheumatoid arthritis and osteoarthritis.
    Grennan DM; Knudson JM; Dunckley J; MacKinnon MJ; Myers DB; Palmer DG
    N Z Med J; 1980 Jan; 91(652):47-50. PubMed ID: 6929437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous synthesis of IgM rheumatoid factor by blood mononuclear cells from patients with rheumatoid arthritis: effect of treatment with gold salts or D-penicillamine.
    Olsen N; Ziff M; Jasin HE
    J Rheumatol; 1984 Feb; 11(1):17-21. PubMed ID: 6699830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-IgG immunoglobulins of the IgG, IgA and IgM types in rheumatoid arthritis].
    Stankaitene DI; Iushenaĭte IaP; Davidson LF
    Vopr Revm; 1976; (1):7-12. PubMed ID: 1086548
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of D-penicillamine on the immunological indices of rheumatoid arthritis patients].
    Sheĭtanov I
    Vutr Boles; 1990; 29(4):59-64. PubMed ID: 2281661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of chrysotherapy on serum protein and immunoglobulin levels, rheumatoid factor, and antiepithelial antibody titers.
    Gottlieb NL; Kiem IM; Penneys NS; Schultz DR
    J Lab Clin Med; 1975 Dec; 86(6):962-72. PubMed ID: 811742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillamine in rheumatoid arthritis.
    Zuckner J; Ramsey RH; Dorner RW; Gantner GE
    Arthritis Rheum; 1970; 13(2):131-8. PubMed ID: 5421723
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating immune complexes in patients with rheumatoid arthritis and the effect of penicillamine in vitro.
    Crawhall JC
    Clin Invest Med; 1984; 7(1):53-8. PubMed ID: 6723125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum copper and caeruloplasmin are higher in seropositive than seronegative rheumatoid arthritis.
    Oriente P; Scarpa R; Cutolo M; Riccio A; Pucino A; Postiglione L
    Eur J Rheumatol Inflamm; 1983; 6(2):163-7. PubMed ID: 6673980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of D-penicillamine on lymphocyte subsets: correlation with clinical response in rheumatoid arthritis.
    Singh RR; Malaviya AN; Malaviya R; Sharma M; Shandilya R; Taneja V; Khare SD; Beri D; Kumar A; Mehra NK
    J Assoc Physicians India; 1994 Mar; 42(3):201-4. PubMed ID: 7860508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG and IgM rheumatoid factors in rheumatoid arthritis. Quantitative response to penicillamine therapy and relationship to disease activity.
    Wernick R; Merryman P; Jaffe I; Ziff M
    Arthritis Rheum; 1983 May; 26(5):593-8. PubMed ID: 6847722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative controlled trial of 2 administration modalities of tiopronin in rheumatoid arthritis].
    Sany J; Combe B; Delecoeuillerie G; Brin S; Paolozzi L
    Rev Rhum Ed Fr; 1993 May; 60(5 Pt 2):36S-44S. PubMed ID: 8162007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.
    Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD
    Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.